19 January 2017
print version

HSE approves 'Clinical Guidelines for Opioid Substitution Treatment'

The ICGP Substance Misuse Programme is delighted to announce that national guidelines on opiate substitution treatment have been approved by the Primary Care Management Team of the HSE.

The ICGP was one of the professional bodies represented on the drafting committee. We would like to thank everyone who took the time to read the draft version of the guidelines and gave us feedback as requested.

To view the guidelines, please see 'Clinical Guidelines for Opioid Substitution Treatment'.

In tandem with these guidelines, the ICGP aims to publish shortly an easy to use desk-top version of the key clinical points in the guidelines which it is hoped GPs will find helpful in their day to day practice.

Dr ├Źde Delargy, Director, Substance Misuse Programme

Dr Des Crowley, Assistant Director, Substance Misuse Programme

Learn More To give you the best possible experience, our sites use cookies. Continuing with cookies enabled means you're OK with this. Click Learn More for more information about our cookies, and how to disable them. ×